Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals -

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals
Information type: Systematic reviews
Source: JAMA Cardiology
Specialities: Cardiovascular system disorders | Nutritional and metabolic disorders
Summary
Meta-analysis of 10 RCTs (n=77,917 high-risk individuals) found omega-3 fatty acids had no significant association with fatal or nonfatal coronary heart disease or any major vascular events, thus there is no support for their use in people with a history of coronary heart disease
UKMi comment
NHS England’s list of items which should not be routinely prescribed in primary care, is currently out for consultation, and includes omega-3 fatty acid compounds.
Related links: NHS England list

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals